EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?. Mediterr J Hematol Infect Dis 2024, 16 (1), e2024073. https://doi.org/10.4084/MJHID.2024.073.